Trial
NCT02292771
A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
GlaxoSmithKline
Collaborators
PPD Development, LP
Condition
Obstetric Labour, Premature
Intervention
Retosiban
Why stopped
The study was stopped due to the feasibility of recruiting the study in a timely manner
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-29